advertisement

WGA Rescources

Cutaneous and Ocular Toxicology 8

Showing records 1 to 8 | Display all abstracts in Cutaneous and Ocular Toxicology

82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Duru Z
Cutaneous and Ocular Toxicology 2020; 39: 21-24
81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Duru Z
Cutaneous and Ocular Toxicology 2019; 38: 370-374
82116 Needling with 5-fluorouracil for encapsulated blebs after Ahmed glaucoma valve implantation
Erdem B
Cutaneous and Ocular Toxicology 2019; 38: 395-400
81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Özsaygılı C
Cutaneous and Ocular Toxicology 2019; 38: 370-374
82116 Needling with 5-fluorouracil for encapsulated blebs after Ahmed glaucoma valve implantation
Imamoglu S
Cutaneous and Ocular Toxicology 2019; 38: 395-400
82613 Preservative-free preserved brimonidine %0.15 preparations in the treatment of glaucoma and ocular hypertension: short term evaluation of efficacy, safety, and potential advantages
Ozsaygili C
Cutaneous and Ocular Toxicology 2020; 39: 21-24
82116 Needling with 5-fluorouracil for encapsulated blebs after Ahmed glaucoma valve implantation
Ercalik NY
Cutaneous and Ocular Toxicology 2019; 38: 395-400
81875 Does using topical latanoprost affect subfoveal choroidal thickness?
Ulusoy DM; Armağan Demirtaş A; Çiçek A; Duru N
Cutaneous and Ocular Toxicology 2019; 38: 370-374

Issue 20-4

Change Issue


advertisement

Bioniko